Benzinga | Nov 19, 2020 06:35AM EST

Entera Bio Q3 EPS $(0.09) Beats $(0.20) Estimate, Sales $50.00K Down From $60.00K YoY

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.20) by 55 percent. This is a 64 percent increase over losses of $(0.25) per share from the same period last year. The company reported $50.00 thousand in sales this quarter. This is a 16.67 percent decrease over sales of $60.00 thousand the same period last year.